首页>
外国专利>
THERAPEUTIC AGENT OR TREATMENT METHOD FOR PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOCYTIC LEUKEMIA (ALL) HAVING IKZF1 MUTATION
THERAPEUTIC AGENT OR TREATMENT METHOD FOR PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOCYTIC LEUKEMIA (ALL) HAVING IKZF1 MUTATION
展开▼
机译：IKZF1突变治疗费城染色体阳性（PH +）急性淋巴细胞白血病（ALL）的治疗剂或治疗方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
According to the present invention, there is provided a pharmaceutical composition for treating Philadelphia chromosome positive lymphocytic leukemia, including a thalidomide derivative and BCR-ABL tyrosine kinase inhibitor. According to the present invention there is also provided a method of treating Philadelphia chromosome positive lymphocytic leukemia, including administering a thalidomide derivative and a BCR-ABL tyrosine kinase inhibitor to a patient suffering from Philadelphia chromosome positive lymphocytic leukemia.
展开▼
